Subscribe for the newsletter
Sign in
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Directory
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
Phase III
Sort By
Newest First
1 / 1
Clinical Outcomes
Alnylam Announces Positive Early Results on Clinical Outcome Measures from ILLUMINATE-A Phase 3 Study of OXLUMO® (lumasiran)
Alnylam Pharmaceuticals
PR-M05-21-003
May 05, 2021
Genentech’s Phase III EMPACTA Study Showed Actemra Reduced the Likelihood of Needing Mechanical Ventilation in Hospitalized Patients With COVID-19 Associated Pneumonia
Genentech
PA1285
Sep 18, 2020
Soligenix, Inc.
Clinical Trials
Soligenix Announces Positive Recommendation on its Phase 3 Clinical Trial for the Treatment of Oral Mucositis
Soligenix, Inc.
PR-M09-19-NI-007
Sep 04, 2019
GSK
Phase III
GSK Announces Positive Headline Results in Phase 3 PRIMA Study of ZEJULA (niraparib) For Patients with Ovarian Cancer
GSK
PR-M07-19-NI-039
Jul 16, 2019
Phase III
Intra-Cellular Therapies Announces Positive Top-line Results from a Phase 3 Trial of Lumateperone in Patients with Bipolar Depression
Nice Insight
PR-M07-19-NI-023
Jul 10, 2019
Inovio Pharmaceuticals, Inc.
Phase III
Inovio Receives European Medicines Agency Certification For Quality and Non-Clinical Data for Its Phase 3 Product, VGX-3100
Inovio Pharmaceuticals, Inc.
PR-M05-19-NI-022
May 08, 2019
Drug Development
New NASH Treatment Achieves Positive Phase III Results
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-M02-19-NI-018
Feb 21, 2019
CStone Pharmaceuticals
Clinical Trials
Avapritinib Receives Phase III Clinical Trial Approval for GIST in China
CStone Pharmaceuticals
PR-M02-19-NI-038
Feb 19, 2019
Eisai
Phase III
Eisai and Purdue Pharma Present Efficacy and Safety Data from Second Pivotal Phase 3 Study: Advances in Sleep and Circadian Science
Eisai
PR-M02-19-NI-010
Feb 06, 2019
Innovent Biologics, Inc.
Oncology
Innovent Announces First Patient Dosed in a Phase III Clinical Trial of Anti-PD-1 Antibody Tyvyt® (Sintilimab injection) as First-line Treatment for Patients with Advanced Esophageal Cancer
Innovent Biologics, Inc.
PR-M01-19-NI-012
Jan 08, 2019
Prometic
Clinical Trial
Prometic to Initiate PBI-4050 Pivotal Phase 3 Clinical Trial in Alström Syndrome
Prometic
PR-M12-18-NI-028
Dec 10, 2018
Amgen
Biosimilars
Amgen Announces Top-Line Results From Phase 3 Study Of ABP 710, Biosimilar Candidate To Infliximab
Amgen
PR-M06-18-NI-100
Jun 29, 2018
Pfizer
Clinical Trials
Pfizer Provides Update on Phase 3 Trial of Axitinib as Adjuvant Treatment for Patients at High Risk of Renal Cell Carcinoma Recurrence After Surgery
Pfizer
PR-M04-18-NI-51
Apr 16, 2018
On Target Laboratories, Inc.
Clinical Trials
First Patient Treated in Pivotal Phase 3 Trial to Evaluate OTL38 in the Detection of Ovarian Cancer
On Target Laboratories, Inc.
PR-M04-18-NI-33
Apr 10, 2018
Pfizer
Clinical Trials
Pfizer Announces Positive Topline Results From Phase 3 ATTR-ACT Study Of Tafamidis In Patients With Transthyretin Cardiomyopathy
Pfizer
PR-M04-18-NI-006
Apr 03, 2018
Clinical Trials
Aimmune’s AR101 Meets Phase 3 Endpoints
Guy Tiene
Nice Insight
PAO-M02-18-NI-020
Feb 22, 2018
Oncology
Device Plus Drug Approved for Bladder Cancer Detection
Nigel Walker
Nice Insight
PAO-M02-18-NI-018
Feb 21, 2018
Eli Lilly and Company
Phase 3
Lilly Announces Positive Top-Line Phase 3 Results for Taltz® (ixekizumab) in Ankylosing Spondylitis (Radiographic Axial Spondyloarthritis)
Eli Lilly and Company
PR-M02-18-NI-61
Feb 16, 2018
Amgen
Oncology
Overall Survival Analysis From KYPROLIS® (Carfilzomib) Phase 3 ASPIRE Trial Published in the Journal of Clinical Oncology
Amgen
PR-M01-18-NI-074
Jan 24, 2018
1 / 1
